And per commentary from Eli Lilly leadership, whose ads you probably saw 100,000 times during Olympics coverage, the tirzepatide GLP-1 shortage is coming to an end very soon. There are 50+ mentions of obesity and weight in Hims & Hers Q2 call
[14] Urgent referral should also be considered for those under 50 with rectal bleeding plus other concerning features, those aged 40+ with unexplained weight loss and abdominal pain, and those aged 60+ with change in bowel habit or iron-deficiency anaemia
1-3 One key misunderstanding is that this is a disease of just lack of willpower, when in fact there is underlying biology that may impede people with obesity from losing weight and keeping it off
New startup to develop a GLP-1 drug for addiction A company called Baseline Therapeutics launched today with a focus on studying a GLP-1 drug for various substance use disorders
If GLP-1 related fatigue persists beyond two months, discuss dose adjustment with your prescriber